Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Geographical heterogeneity in the analysis of factors associated with leprosy in an endemic area of Brazil: are we eliminating the disease?

Authors: Mônica Duarte-Cunha, Geraldo Marcelo da Cunha, Reinaldo Souza-Santos

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

The leprosy transmission chain is very complex and, in order to intervene in this transmission, more must be known about the factors linked to falling ill. There are doubts as to the influence of population size, population density and the disease’s magnitude in detection rate trends. This paper aimed to identify factors associated with detection of leprosy in an endemic municipality of Rio de Janeiro State, Brazil.

Methods

This ecological study in Duque de Caxias municipality, Rio de Janeiro State, Brazil, used neighbourhoods (bairros) as the unit of analysis. Selecting new cases of leprosy detected from 1998 to 2006, the analysis examined clinical, socioeconomic and service variables using a Poisson log-Normal model.

Results

In the municipality overall, 2572 new cases were detected, a rate of 3.70 cases/10,000 inhabitants. The results describe a heterogeneous distribution of cases and rates in the municipality. The final model displayed a significant association with indeterminate clinical form (β = 2.599), proportion of homes with running water (β = -2.334) and presence of a decentralised health care unit (β = 0.524).

Conclusion

Although the results indicate progress towards elimination of the disease in the municipality, high rates continue to be detected in municipal sub-regions. The following question can thus be posed: over how wide a geographical area could the disease be thoroughly eliminated, given this heterogeneity within a small municipality?
Literature
1.
go back to reference WHO. Global leprosy situation, beginning of 2008. Relevé Épidémiologique Hebd Sect Hygiène Secrétariat Société Nations Wkly Epidemiol Rec Health Sect Secr Leag Nations. 2008;83:293–300. WHO. Global leprosy situation, beginning of 2008. Relevé Épidémiologique Hebd Sect Hygiène Secrétariat Société Nations Wkly Epidemiol Rec Health Sect Secr Leag Nations. 2008;83:293–300.
2.
go back to reference Van Beers SM, de Wit MY, Klatser PR. The epidemiology of Mycobacterium leprae: recent insight. FEMS Microbiol Lett. 1996;136:221–30.CrossRefPubMed Van Beers SM, de Wit MY, Klatser PR. The epidemiology of Mycobacterium leprae: recent insight. FEMS Microbiol Lett. 1996;136:221–30.CrossRefPubMed
3.
go back to reference Meima A, Irgens LM, van Oortmarssen GJ, Richardus JH, Habbema JDF. Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach. Int J Epidemiol. 2002;31:991–1000.CrossRefPubMed Meima A, Irgens LM, van Oortmarssen GJ, Richardus JH, Habbema JDF. Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach. Int J Epidemiol. 2002;31:991–1000.CrossRefPubMed
4.
go back to reference Fine PE, Sterne JA, Pönnighaus JM, Bliss L, Saui J, Chihana A, et al. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol. 1997;146:91–102.CrossRefPubMed Fine PE, Sterne JA, Pönnighaus JM, Bliss L, Saui J, Chihana A, et al. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol. 1997;146:91–102.CrossRefPubMed
5.
go back to reference De Matos HJ, Duppre N, Alvim MF, MachadoVieira LM, Sarno EN, Struchiner CJ. Leprosy epidemiology in a cohort of household contacts in Rio de Janeiro (1987-1991). Cad Saúde Pública. 1999;15:533–42.CrossRefPubMed De Matos HJ, Duppre N, Alvim MF, MachadoVieira LM, Sarno EN, Struchiner CJ. Leprosy epidemiology in a cohort of household contacts in Rio de Janeiro (1987-1991). Cad Saúde Pública. 1999;15:533–42.CrossRefPubMed
6.
go back to reference Sales AM, Ponce de Leon A, Düppre NC, Hacker MA, Nery JAC, Sarno EN, et al. Leprosy among patient contacts: a multilevel study of risk factors. PLoS Negl Trop Dis. 2011;5:1013.CrossRef Sales AM, Ponce de Leon A, Düppre NC, Hacker MA, Nery JAC, Sarno EN, et al. Leprosy among patient contacts: a multilevel study of risk factors. PLoS Negl Trop Dis. 2011;5:1013.CrossRef
7.
go back to reference Bührer SS, Smits HL, Gussenhoven GC, van Ingen CW, Klatser PR. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am J Trop Med Hyg. 1998;58:133–6.PubMed Bührer SS, Smits HL, Gussenhoven GC, van Ingen CW, Klatser PR. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am J Trop Med Hyg. 1998;58:133–6.PubMed
8.
go back to reference Stefani MM, Martelli CM, Morais-Neto OL, Martelli P, Costa MB, de Andrade AL. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1998;66:356–64. Stefani MM, Martelli CM, Morais-Neto OL, Martelli P, Costa MB, de Andrade AL. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1998;66:356–64.
9.
go back to reference Van Beers S, Hatta M, Klatser PR. Seroprevalence rates of antibodies to phenolic glycolipid-I among school children as an indicator of leprosy endemicity. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1999;67:243–9. Van Beers S, Hatta M, Klatser PR. Seroprevalence rates of antibodies to phenolic glycolipid-I among school children as an indicator of leprosy endemicity. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1999;67:243–9.
10.
go back to reference Oskam L, Slim E, Bührer-Sékula S. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev. 2003;74:196–205.PubMed Oskam L, Slim E, Bührer-Sékula S. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev. 2003;74:196–205.PubMed
11.
go back to reference Guerrero MI, Arias MT, Garcés MT, León CI. Developing and using a PCR test to detect subclinical Mycobacterium leprae infection. Rev Panam Salud Pública Pan Am J Public Health. 2002;11:228–34.CrossRef Guerrero MI, Arias MT, Garcés MT, León CI. Developing and using a PCR test to detect subclinical Mycobacterium leprae infection. Rev Panam Salud Pública Pan Am J Public Health. 2002;11:228–34.CrossRef
12.
go back to reference de Almeida EC, Martinez AN, Maniero VC, Sales AM, Duppre NC, Sarno EN, et al. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood and nasal secretion of Brazilian household contacts. Mem Inst Oswaldo Cruz. 2004;99:509–11.CrossRefPubMed de Almeida EC, Martinez AN, Maniero VC, Sales AM, Duppre NC, Sarno EN, et al. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood and nasal secretion of Brazilian household contacts. Mem Inst Oswaldo Cruz. 2004;99:509–11.CrossRefPubMed
13.
go back to reference Lobato J, Costa MP, Reis EDM, Gonçalves MA, Spencer JS, Brennan PJ, et al. Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection. Lepr Rev. 2011;82:389–401.PubMed Lobato J, Costa MP, Reis EDM, Gonçalves MA, Spencer JS, Brennan PJ, et al. Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection. Lepr Rev. 2011;82:389–401.PubMed
14.
go back to reference Lockwood DNJ, Suneetha S. Leprosy: too complex a disease for a simple elimination paradigm. Bull World Health Organ. 2005;83:230–5.PubMedPubMedCentral Lockwood DNJ, Suneetha S. Leprosy: too complex a disease for a simple elimination paradigm. Bull World Health Organ. 2005;83:230–5.PubMedPubMedCentral
15.
go back to reference Meima A, Gupte MD, van Oortmarssen GJ, Habbema JD. Trends in leprosy case detection rates. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1997;65:305–19. Meima A, Gupte MD, van Oortmarssen GJ, Habbema JD. Trends in leprosy case detection rates. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1997;65:305–19.
16.
go back to reference Fine PEM. Global leprosy statistics: a cause for pride, or frustration? Lepr Rev. 2006;77:295–7.PubMed Fine PEM. Global leprosy statistics: a cause for pride, or frustration? Lepr Rev. 2006;77:295–7.PubMed
17.
go back to reference Fischer EAJ, de Vlas SJ, Habbema JDF, Richardus JH. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study. PLoS Negl Trop Dis. 2011;5, e1330.CrossRefPubMedPubMedCentral Fischer EAJ, de Vlas SJ, Habbema JDF, Richardus JH. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study. PLoS Negl Trop Dis. 2011;5, e1330.CrossRefPubMedPubMedCentral
18.
go back to reference Noordeen SK. Eliminating leprosy as a public health problem; why the optimism is justified. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1995;63:559–66. Noordeen SK. Eliminating leprosy as a public health problem; why the optimism is justified. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 1995;63:559–66.
19.
go back to reference Visschedijk J, van de Broek J, Eggens H, Lever P, van Beers S, Klatser P. Mycobacterium leprae–millennium resistant! Leprosy control on the threshold of a new era. Trop Med Int Health TM IH. 2000;5:388–99.CrossRefPubMed Visschedijk J, van de Broek J, Eggens H, Lever P, van Beers S, Klatser P. Mycobacterium leprae–millennium resistant! Leprosy control on the threshold of a new era. Trop Med Int Health TM IH. 2000;5:388–99.CrossRefPubMed
20.
go back to reference Meima A, Smith WCS, van Oortmarssen GJ, Richardus JH, Habbema JDF. The future incidence of leprosy: a scenario analysis. Bull World Health Organ. 2004;82:373–80.PubMedPubMedCentral Meima A, Smith WCS, van Oortmarssen GJ, Richardus JH, Habbema JDF. The future incidence of leprosy: a scenario analysis. Bull World Health Organ. 2004;82:373–80.PubMedPubMedCentral
21.
go back to reference Noordeen SK, Roxas MG, Fine PE, Smith WC, Feenstra P, Gokhale SD, et al. Eliminating leprosy as a public health problem–is the optimism justified? World Health Forum. 1996;17:109–44.PubMed Noordeen SK, Roxas MG, Fine PE, Smith WC, Feenstra P, Gokhale SD, et al. Eliminating leprosy as a public health problem–is the optimism justified? World Health Forum. 1996;17:109–44.PubMed
22.
go back to reference Alberts CJ, Smith WCS, Meima A, Wang L, Richardus JH. Potential effect of the World Health Organization’s 2011-2015 global leprosy strategy on the prevalence of grade 2 disability: a trend analysis. Bull World Health Organ. 2011;89:487–95.CrossRefPubMedPubMedCentral Alberts CJ, Smith WCS, Meima A, Wang L, Richardus JH. Potential effect of the World Health Organization’s 2011-2015 global leprosy strategy on the prevalence of grade 2 disability: a trend analysis. Bull World Health Organ. 2011;89:487–95.CrossRefPubMedPubMedCentral
23.
go back to reference SVS. Relatório de Gestão. Coordenação Geral Do Programa Nacional de Controle Da Hanseníase – CGPNCH Janeiro de 2009 a Dezembro de 2010. Brasília: Ministério da Saúde; 2011. SVS. Relatório de Gestão. Coordenação Geral Do Programa Nacional de Controle Da Hanseníase – CGPNCH Janeiro de 2009 a Dezembro de 2010. Brasília: Ministério da Saúde; 2011.
24.
go back to reference WHO, editor. Guide to Eliminate Leprosy as a Public Health Problem. Geneve: World Health Organization; 2000. WHO, editor. Guide to Eliminate Leprosy as a Public Health Problem. Geneve: World Health Organization; 2000.
25.
go back to reference Report of the committee on classification. International Congress of leprosy, Madrid; 1953. Int J Lepr Other Mycobact Dis. 1953;21:504–10. Report of the committee on classification. International Congress of leprosy, Madrid; 1953. Int J Lepr Other Mycobact Dis. 1953;21:504–10.
26.
go back to reference Pardillo FEF, Fajardo TT, Abalos RM, Scollard D, Gelber RH. Methods for the classification of leprosy for treatment purposes. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;44:1096–9.CrossRef Pardillo FEF, Fajardo TT, Abalos RM, Scollard D, Gelber RH. Methods for the classification of leprosy for treatment purposes. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;44:1096–9.CrossRef
27.
go back to reference Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa M-T, Yamamura M, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301:1527–30.CrossRefPubMed Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa M-T, Yamamura M, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301:1527–30.CrossRefPubMed
28.
go back to reference Knorr-Held L, Besag J. Modelling risk from a disease in time and space. Stat Med. 1998;17:2045–60.CrossRefPubMed Knorr-Held L, Besag J. Modelling risk from a disease in time and space. Stat Med. 1998;17:2045–60.CrossRefPubMed
29.
go back to reference Gelman A. Data Analysis Using Regression and Multilevel/hierarchical Models. Cambridge ; New York: Cambridge University Press; 2007 [Analytical Methods for Social Research]. Gelman A. Data Analysis Using Regression and Multilevel/hierarchical Models. Cambridge ; New York: Cambridge University Press; 2007 [Analytical Methods for Social Research].
30.
go back to reference Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B Stat Methodol. 2002;64:583–639.CrossRef Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B Stat Methodol. 2002;64:583–639.CrossRef
31.
go back to reference Santos S, Vieira W. Introdução À Estatística Espacial Para a Saúde Pública. Brasília: Ministério da Saúde; 2007 [Série Capacitação E Atualização Em Geoprocessamento Em Saúde; 3]. Santos S, Vieira W. Introdução À Estatística Espacial Para a Saúde Pública. Brasília: Ministério da Saúde; 2007 [Série Capacitação E Atualização Em Geoprocessamento Em Saúde; 3].
32.
go back to reference Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Ser B Stat Methodol. 2009;71:319–92.CrossRef Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Ser B Stat Methodol. 2009;71:319–92.CrossRef
33.
go back to reference Held L, Schrodle B, Rue H. Posterior and Cross-validatory Predictive Checks: A Comparison of MCMC and INLA. In: Statistical Modelling and Regression Structures: Festschrift in Honour of Ludwig Fahrmeir. 472nd ed. Heidelberg ; New York: Physica; 2010. Held L, Schrodle B, Rue H. Posterior and Cross-validatory Predictive Checks: A Comparison of MCMC and INLA. In: Statistical Modelling and Regression Structures: Festschrift in Honour of Ludwig Fahrmeir. 472nd ed. Heidelberg ; New York: Physica; 2010.
34.
go back to reference Matsuoka M, Maeda S, Kai M, Nakata N, Chae GT, Gillis TP, et al. Mycobacterium leprae typing by genomic diversity and global distribution of genotypes. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 2000;68:121–8. Matsuoka M, Maeda S, Kai M, Nakata N, Chae GT, Gillis TP, et al. Mycobacterium leprae typing by genomic diversity and global distribution of genotypes. Int J Lepr Mycobact Dis Off Organ Int Lepr Assoc. 2000;68:121–8.
35.
go back to reference Cavaliere F. Estratégias para o exame de contatos de hanseníase: Avaliação de desempenho em área urbana endêmica do RJ. Dissertação de Mestrado. Rio de Janeiro: Universidade Federal do Rio de Janeiro; 2005. Cavaliere F. Estratégias para o exame de contatos de hanseníase: Avaliação de desempenho em área urbana endêmica do RJ. Dissertação de Mestrado. Rio de Janeiro: Universidade Federal do Rio de Janeiro; 2005.
36.
go back to reference Duarte-Cunha M, Souza-Santos R, HJ de M, MLW de O. Epidemiological aspects of leprosy: a spatial approach. Cad Saúde Pública. 2012;28:1143–55.CrossRefPubMed Duarte-Cunha M, Souza-Santos R, HJ de M, MLW de O. Epidemiological aspects of leprosy: a spatial approach. Cad Saúde Pública. 2012;28:1143–55.CrossRefPubMed
37.
go back to reference SMSDC. Relatório Anual Da Secretaria Municipal de Saúde. Duque de Caxias: SMSDC; 2004. SMSDC. Relatório Anual Da Secretaria Municipal de Saúde. Duque de Caxias: SMSDC; 2004.
38.
go back to reference Andrade V, Ignotti E. Secular trends of new leprosy cases diagnosed in Brazil during 1987-2006. Indian J Lepr. 2008;80:31–8.PubMed Andrade V, Ignotti E. Secular trends of new leprosy cases diagnosed in Brazil during 1987-2006. Indian J Lepr. 2008;80:31–8.PubMed
39.
go back to reference Atkinson S, Haran D. Back to basics: does decentralization improve health system performance? Evidence from Ceara in north-east Brazil. Bull World Health Organ. 2004;82:822–7.PubMedPubMedCentral Atkinson S, Haran D. Back to basics: does decentralization improve health system performance? Evidence from Ceara in north-east Brazil. Bull World Health Organ. 2004;82:822–7.PubMedPubMedCentral
40.
go back to reference Hatta M, Makino M, Ratnawati, Mashudi, Yadi, Sabir M, et al. Detection of serum antibodies to M. leprae major membrane protein-II in leprosy patients from Indonesia. Lepr Rev. 2009;80:402.PubMed Hatta M, Makino M, Ratnawati, Mashudi, Yadi, Sabir M, et al. Detection of serum antibodies to M. leprae major membrane protein-II in leprosy patients from Indonesia. Lepr Rev. 2009;80:402.PubMed
Metadata
Title
Geographical heterogeneity in the analysis of factors associated with leprosy in an endemic area of Brazil: are we eliminating the disease?
Authors
Mônica Duarte-Cunha
Geraldo Marcelo da Cunha
Reinaldo Souza-Santos
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0924-x

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.